There are 2949 resources available
1465P - A nationwide population-based study comparing treatment patterns and outcomes in synchronous versus metachronous metastatic esophageal and gastric adenocarcinoma
Presenter: Marieke Pape
Session: E-Poster Display
Resources:
Abstract
1466P - Clinical implications of neutrophil-to-lymphocyte ratio and MDSC kinetics in gastric cancer patients treated with ramucirumab plus paclitaxel
Presenter: Hyung-don Kim
Session: E-Poster Display
Resources:
Abstract
1467P - The development and verification of nomogram to predict the survival prognosis of patients with esophageal squamous cell carcinoma
Presenter: Ling Xiao
Session: E-Poster Display
Resources:
Abstract
1468P - Characteristics and prognosis of gastric cancer (GC) in adolescents and young adults (AYA) in Singapore
Presenter: Evelyn Wong
Session: E-Poster Display
Resources:
Abstract
1469P - The humanistic burden reported by patients with unresectable locally advanced or metastatic (adv/met) gastric cancer (GC), gastroesophageal junction cancer (GEJC) and esophageal adenocarcinoma (EAC): An international real-world survey
Presenter: Jennifer Hall
Session: E-Poster Display
Resources:
Abstract
1470P - Urban-rural differences in outcomes of patients with advanced gastroesophageal cancers
Presenter: Jenny Peng
Session: E-Poster Display
Resources:
Abstract
1471P - 3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients
Presenter: Manuel Cabeza
Session: E-Poster Display
Resources:
Abstract
1472P - Association among blood transfusion, post-operative infectious complications, and cancer specific survival in patients with stage II/III gastric cancer after radical gastrectomy: Emphasizing benefit from chemotherapy
Presenter: Hua Xiao
Session: E-Poster Display
Resources:
Abstract
1473P - Parameters of complete blood count might predict the prognosis of patients with advanced gastric cancer
Presenter: Osman Sutcuoglu
Session: E-Poster Display
Resources:
Abstract
1474P - Immune-inflammatory indexes and BMI as predictors of outcome and treatment response in advanced gastric cancer receiving ramucirumab-containing second-line
Presenter: Margherita Rimini
Session: E-Poster Display
Resources:
Abstract